Company Information & Drug Savings for BioCryst Pharmaceuticals Medications
BioCryst Pharmaceuticals is a biotechnology company developing novel oral small-molecule medicines for rare diseases. Based in Durham, North Carolina, BioCryst created ORLADEYO (berotralstat), the first oral once-daily therapy for preventing hereditary angioedema (HAE) attacks. The company’s structure-based drug design approach targets enzyme inhibitors for rare enzyme deficiency disorders and complement-mediated diseases.
How to Contact Biocryst Pharmaceuticals
Phone
1-919-859-1302Medical Disclaimer
NowPatient has taken all reasonable steps to ensure that all material is factually accurate, complete, and current. However, the knowledge and experience of a qualified healthcare professional should always be sought after instead of using the information on this page. Before taking any drug, you should always speak to your doctor or another qualified healthcare provider.
The information provided here about medications is subject to change and is not meant to include all uses, precautions, warnings, directions, drug interactions, allergic reactions, or negative effects. The absence of warnings or other information for a particular medication does not imply that the medication or medication combination is appropriate for all patients or for all possible purposes.
Experienced a Side Effect?
Report to Yellow Card (UK) or MedWatch (US)
